NCT06581133

Brief Summary

Epilepsy affects millions worldwide, with 40% of patients experiencing uncontrolled seizures despite medication. Comprehensive epilepsy centers recommend continuous video-electroencephalography monitoring to define seizure type and distinguish mimickers. This process, however, is resource-intensive, with lengthy hospital stays. The investigators' recent study identified a heightened association between arousals and epileptic activity in drug-resistant focal epilepsy patients. Building on these findings, the investigators aim to explore whether disrupting sleep with an alarm system triggers earlier occurrence of seizures, potentially offering insights to reduce hospital stay durations in epilepsy monitoring units.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
1.7 years until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

February 11, 2026

Status Verified

June 1, 2025

Enrollment Period

1.5 years

First QC Date

April 4, 2024

Last Update Submit

February 9, 2026

Conditions

Keywords

epilepsy monitoring unit

Outcome Measures

Primary Outcomes (4)

  • Seizure frequency during EMU (epilepsy monitoring unit) stay

    Average number of seizures per day, recorded daily during the patient's EMU stay. Measured for all groups of patients.

    1 month after the EMU stay (up to 9 weeks)

  • Duration of EMU (epilepsy monitoring unit) admission

    Overall duration (in days) of the EMU admission. Measured for all groups of patients.

    1 month after the EMU stay (up to 9 weeks)

  • Average interictal spike rates

    Average number of spike rates, taken from a random segment for each day and night. Measured for all groups of patients.

    1 month after the EMU stay (up to 9 weeks)

  • Change in sleep quality

    As determined by changes in Pittsburgh Sleep Quality Index scores. A higher score indicates increased sleep disturbances.

    Baseline (Day 1), last day of EMU stay (up to 5 weeks), 1 month after the EMU stay (up to 9 weeks)

Study Arms (2)

Alarm

EXPERIMENTAL

Patients in the alarm group will have an alarm system placed in their room, scheduled to sound at 4 timepoints during the night (specific timepoints adjusted based on patient's preferred bed times). This intervention will stop when the clinical team has collected sufficient seizures for clinical decision making.

Device: Alarm system

Control

NO INTERVENTION

Patients in the control group will have an alarm system placed in their room, but the alarm system will not sound during any of the nights during their EMU admission.

Interventions

Generic alarm system programmed to sound during the night to try to induce arousals from sleep.

Alarm

Eligibility Criteria

Age14 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 14 to 60 years
  • EMU monitoring for presurgical evaluations
  • Average 2-3 seizures per week based on pre-admission seizure diary
  • Sleep as a known seizure trigger

You may not qualify if:

  • \- Multiple seizures a day based on pre-admission seizure diary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Drug Resistant Epilepsy

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Birgit Frauscher, MD PD

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Birgit Frauscher, MD PD

CONTACT

Mays Khweileh, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This is a single blind study and patients will not know which group they are in.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: During their epilepsy monitoring unit (EMU) admission, patients will be divided into either the alarm group or the control group. Patients in the alarm group will have an alarm system placed in their room, scheduled to sound at several timepoints during the night. This intervention will be conducted throughout the whole EMU admission. Patients in the control group will have an alarm system placed in their room, but the alarm system will not sound during any of the nights during their EMU admission.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2024

First Posted

September 3, 2024

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

February 11, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share